Neuromuscular Dynamics LLC

Neuromuscular Dynamics LLC is a woman-owned, minority-owned small business registered in SAM.gov since 2017, specializing in developing innovative sensorimotor training technologies. The company's primary product is the Leg Dexterity System, a patented portable device designed to enhance neuromuscular control through dynamic foot-ground interactions. Founded by Dr. Valero-Cuevas, a biomedical engineering professor at the University of Southern California, the company focuses on creating advanced training systems that improve sensorimotor performance across medical and aerospace applications.

The federal contract awards for Neuromuscular Dynamics LLC demonstrate a focused engagement with NASA's Shared Services Center, specifically targeting sensorimotor performance research. Their sole federal contract award is a $192,290 grant aimed at developing a countermeasure system for astronauts experiencing neuromuscular control performance decrements in microgravity environments. The research involves quantifying dynamic stability and neuromuscular control through an 8-week strength and conditioning regimen supplemented with the Leg Dexterity System training. The project aligns with NASA's objective to develop integrated sensorimotor countermeasure systems for spaceflight, with the ultimate goal of improving astronauts' physical performance and adaptability in challenging environmental conditions.

Neuromuscular Dynamics LLC has secured two significant federal grant awards, both focusing on advancing the Leg Dexterity System's applications. The first, a $1,800,418 grant from the National Institute on Aging, aims to clinically validate the system's potential in managing knee osteoarthritis. This project involves a longitudinal, blinded trial comparing Leg Dexterity training with placebo exercises, with the goal of enabling the system's use in approximately 1,600 physical therapy clinics within five years. The second grant, also from NASA's Shared Services Center, is similar to their contract award, emphasizing research into sensorimotor control enhancement for astronauts. Both grants demonstrate the company's commitment to developing innovative, scientifically rigorous solutions for improving human sensorimotor performance across medical and aerospace domains.